<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Issa ME</submitter><pubmed_abstract>Multiple myeloma (MM) remains an incurable malignancy despite the development of novel therapeutics. This is believed to be due to a subset of rare chemotherapy-resistant cancer stem cells (CSCs). Differentiation therapy represents one strategy aimed at reducing the stemness of CSCs. The anticancer effect of withaferin A (WFA) was studied in MM-CSCs and RPMI 8226 MM tumoral plasma cells (RPMIs). WFA exhibited growth inhibitory effects in both MM-CSCs and RPMIs, with IC&lt;sub>50&lt;/sub> values of 649 and 224 nM, respectively. WFA also induced a G&lt;sub>2&lt;/sub> cell cycle arrest, as well as cell death and apoptosis. Although, WFA did not exhibit a direct anti-migratory effect, a remarkable morphological change was observed in MM-CSCs in response to WFA treatment. Using qPCR gene expression analyses, WFA caused a reduction in stemness markers, and a promotion of differentiation markers in MM-CSCs. These results warrant further investigation of WFA in relevant MM animal models.</pubmed_abstract><journal>MedChemComm</journal><pagination>112-121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6071845</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells.</pubmed_title><pmcid>PMC6071845</pmcid><pubmed_authors>Issa ME</pubmed_authors><pubmed_authors>Cuendet M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells.</name><description>Multiple myeloma (MM) remains an incurable malignancy despite the development of novel therapeutics. This is believed to be due to a subset of rare chemotherapy-resistant cancer stem cells (CSCs). Differentiation therapy represents one strategy aimed at reducing the stemness of CSCs. The anticancer effect of withaferin A (WFA) was studied in MM-CSCs and RPMI 8226 MM tumoral plasma cells (RPMIs). WFA exhibited growth inhibitory effects in both MM-CSCs and RPMIs, with IC&lt;sub>50&lt;/sub> values of 649 and 224 nM, respectively. WFA also induced a G&lt;sub>2&lt;/sub> cell cycle arrest, as well as cell death and apoptosis. Although, WFA did not exhibit a direct anti-migratory effect, a remarkable morphological change was observed in MM-CSCs in response to WFA treatment. Using qPCR gene expression analyses, WFA caused a reduction in stemness markers, and a promotion of differentiation markers in MM-CSCs. These results warrant further investigation of WFA in relevant MM animal models.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jan</publication><modification>2025-04-19T20:58:57.621Z</modification><creation>2019-03-26T23:51:29Z</creation></dates><accession>S-EPMC6071845</accession><cross_references><pubmed>30108696</pubmed><doi>10.1039/c6md00410e</doi></cross_references></HashMap>